CodaMetrix’s AI Platform Now Available in Epic Toolbox to Transform $20B Medical Coding Sector
CodaMetrix’s AI platform, developed with and used by 20 top U.S. health systems, efficiently and accurately transforms patient records into...
Clinical Trial
Results From European Randomized Controlled Study Using XVIVO’s Heart Technology Published in The Lancet
GOTHENBURG, SWEDEN / ACCESSWIRE / August 16, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, the results of the European randomized...
Genmab Announces Changes to its Executive Committee
Media Release COPENHAGEN, Denmark; August 16, 2024 Rayne Waller joins as Executive Vice President and Chief Technology OfficerBrad Bailey appointed...
Safety Shot Releases Second Quarter 2024 Results and Corporate Highlights
- Q2 Revenues Increased 40%- Q2 Operating Expenses Decreased 17.7%- Recent Clinical Trial Confirms Dramatic Reduction of Blood Alcohol Content-...
AIM ImmunoTech Reports Second Quarter 2024 Financial Results and Provides Corporate Update
– Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications – Company...
Therma Bright’s AI-Powered Digital Cough Technology Being Considered as Partner Technology in New Chronic Cough Drug Clinical Trial
Toronto, Ontario--(Newsfile Corp. - August 16, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), a...
4G Clinical Announces Appointment of Life Science Service and Tech Leader Dr. Ronan Brown as New Chief Operating Officer
Brown brings years of industry expertise to oversee and maximize 4G Clinical's operational efficiency and excellence. WELLESLEY, Mass., Aug. 15,...
CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results
Potentially pivotal GBM study evaluating lead program, Berubicin, enrollment completed; Topline data expected in the first half of 2025Recent strategic...
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
Closed new licensing agreement with GSK worth up to €1.45 billion, including €400 million upfront; provides strong validation of CureVac's...
CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma
First patient administered in dose-confirmation Part B of Phase 1 study with mRNA-based, multiepitope cancer vaccine candidate CVGBMPart B expected...
CureVac Names Oncologist and Drug Development Expert Dr. Mehdi Shahidi to Supervisory Board
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / August 15, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
BioNxt Signs Letter of Intent with Gen-Plus GmbH & Co KG for Potential Business Collaborations
VANCOUVER, BC / ACCESSWIRE / August 15, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to...
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Marlborough, Massachusetts--(Newsfile Corp. - August 14, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch...
Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
WINNIPEG, MB / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...
Medicure Reports Financial Results for Quarter Ended June 30, 2024
WINNIPEG, ON / ACCESSWIRE / August 14, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...
Zomedica Announces Second Quarter 2024 Financial Results: Revenue of $6.1 Million; 71% Gross Margin, and $83.0 Million in Liquidity to Support Growth
Diagnostic revenues up 68% year-over-year ANN ARBOR, MI / ACCESSWIRE / August 14, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica"...
Monogram Technologies Reports Second Quarter 2024 Financial Results
Submitted FDA 510(k) Application and Passed FDA Administrative Review for the mBôs TKA SystemSecured Initial Strategic Multicenter Clinical Trial Collaboration...
Examining the Role of AI in Advancing Healthcare Efficiency
USA News Group CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Aug. 14, 2024 /PRNewswire/ -- USA News Group –...
Veridix AI, part of Emmes Group, Announces New Protocol Digitization Capabilities
Protocol digitization extracts structured data elements from unstructured textAutomates database study builds, reducing build timelines by up to 30%Deployed within...